These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 1818823)

  • 1. [The inhibition of keratoplasty rejection with topical cyclosporin A].
    Jai H; Zhang RX
    Zhonghua Yan Ke Za Zhi; 1991 Nov; 27(6):345-7. PubMed ID: 1818823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cyclosporin A eyedrops in the prevention of high-risk corneal graft rejection. II. Postoperative clinical results].
    Goichot-Bonnat L; Chemla P; Pouliquen Y
    J Fr Ophtalmol; 1987; 10(3):213-7. PubMed ID: 3301994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of topical cyclosporine 0.05% for prevention of cornea transplant rejection episodes.
    Price MO; Price FW
    Ophthalmology; 2006 Oct; 113(10):1785-90. PubMed ID: 16884779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical cyclosporin A in the management of postkeratoplasty glaucoma.
    Perry HD; Donnenfeld ED; Kanellopoulos AJ; Grossman GA
    Cornea; 1997 May; 16(3):284-8. PubMed ID: 9143799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local therapy of corneal allograft rejection with cyclosporine.
    Zhao JC; Jin XY
    Am J Ophthalmol; 1995 Feb; 119(2):189-94. PubMed ID: 7832225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical study on the endothelial immune rejection after penetrating keratoplasty].
    Shi WY; Wang X; Xie LX
    Zhonghua Yan Ke Za Zhi; 2005 Feb; 41(2):145-9. PubMed ID: 15840342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Six years' experience with systemic cyclosporin A prophylaxis in high-risk perforating keratoplasty patients. A retrospective study.
    Sundmacher R; Reinhard T; Heering P
    Ger J Ophthalmol; 1992; 1(6):432-6. PubMed ID: 1490144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical cyclosporin A in the treatment of corneal graft reaction.
    Hoffmann F; Wiederholt M
    Cornea; 1986; 5(3):129. PubMed ID: 2980826
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effects of 1alpha, 25-dihydroxyvitamin D3 on the acute immune rejection and corneal neovascularization in high-risk penetrating keratoplasty in rats].
    Dang ST; Lu XH; Zhou J; Bai L
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Aug; 24(8):892-6, 903. PubMed ID: 15321754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention and treatment of corneal graft rejection: current practice patterns (2004).
    Randleman JB; Stulting RD
    Cornea; 2006 Apr; 25(3):286-90. PubMed ID: 16633028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cyclosporin A combined with dexamethasone in preventing and treating immune rejection after penetrating keratoplasty].
    Xi XH; Qin B; Jiang DY
    Hunan Yi Ke Da Xue Xue Bao; 2003 Dec; 28(6):627-30. PubMed ID: 15804077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ten-year postoperative results of penetrating keratoplasty.
    Ing JJ; Ing HH; Nelson LR; Hodge DO; Bourne WM
    Ophthalmology; 1998 Oct; 105(10):1855-65. PubMed ID: 9787355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy of topical cyclosporine A on keratoplasty rejection in rats].
    Zhang W; Pan Z; Zhai C
    Zhonghua Yan Ke Za Zhi; 2001 Mar; 37(2):140-3. PubMed ID: 11864411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of topical FK506 in a corneal graft rejection model in Lewis rats.
    Hikita N; Lopez JS; Chan CC; Mochizuki M; Nussenblatt RB; de Smet MD
    Invest Ophthalmol Vis Sci; 1997 Apr; 38(5):901-9. PubMed ID: 9112986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic use of topical cyclosporine.
    Kaan G; Ozden O
    Ann Ophthalmol; 1993 May; 25(5):182-6. PubMed ID: 8517589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a topical cyclosporine A prodrug on corneal graft rejection in rats.
    Bourges JL; Lallemand F; Agla E; Besseghir K; Dumont JM; BenEzra D; Gurny R; Behar-Cohen F
    Mol Vis; 2006 Dec; 12():1461-6. PubMed ID: 17167400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment with cyclosporin A, with low doses, in high-risk penetrating keratoplasties. A bi-centric study of 90 cases].
    Robert PY; Delbosc B; Preux PM; Monnot PH; Drouet M; Peyronnet P; Adenis JP
    J Fr Ophtalmol; 1997; 20(7):507-14. PubMed ID: 9499974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of cyclosporin A eyedrops in the prevention of corneal graft rejection in man. I. Preoperative development of 4 eyes with metaherpetic keratitis].
    Goichot-Bonnat L; De Beauregard C; Saragoussi JJ; Pouliquen Y
    J Fr Ophtalmol; 1987; 10(3):207-11. PubMed ID: 3301993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flow-cytometric analysis of peripheral lymphocytes in the rat following penetrating keratoplasty and immunosuppressive treatment.
    Klebe S; Coupland SE; Krause L; Hoffmann F
    Ger J Ophthalmol; 1996 May; 5(3):137-45. PubMed ID: 8803575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corneal endothelium and postoperative outcomes 15 years after penetrating keratoplasty.
    Patel SV; Hodge DO; Bourne WM
    Am J Ophthalmol; 2005 Feb; 139(2):311-9. PubMed ID: 15733993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.